Bio Essence Corp
BIOE· OTC
BIOEBio Essence Corp
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001213900-21-041842
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $235.93K | $205.09K |
| Net Income | -$163.54K | -$184.45K |
| EPS Diluted | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end
